2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$3.75+$0.05 (+1.35%)
Price as of Jul 14, 2026 4:08 AM EDT- $818.6MMarket Cap
- 54.81%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$3.75+$0.05 (+1.35%)
Earnings Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 21 |
Momentum Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -31.53% | ||
12-Month Momentum | 20.25% | ||
3-Month Risk Adjusted Momentum | -160.86% | ||
12-Month Risk Adjusted Momentum | 21.96% |
True Yield
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 2.79% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |